Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

Calgene Inc.

(CGNE)

Business: Agbiotech

Andre Garnet of A.G. Edwards & Sons lowered his rating from "buy" to "hold"

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE